Brind.

ABR reflected analyst recommendations for Eli Lilly and Company.

2 reports, 1 independent Updated Jul 18

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

ABR reflected analyst recommendations for Eli Lilly and Company.

Who's involved

What this event is mainly about

ABR Eli Lilly and Company

Keep exploring

The entities involved

ABR
Czech company

Nothing else this week.
Eli Lilly and Company
American pharmaceutical company
- Trade data and legislative control are currently influencing market sentiment and corporate operations.Sat 00:04
- Agreement between Eli Lilly and Hims & Hers Health expands access to Lilly's medicines.Fri 14:13

Related events

Coverage

Newest first; wire copies grouped

Jul 18ZacksBrokers Suggest Investing in Lilly (LLY): Read This Before Placing a Bet The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a sto
Jul 2Unknown outlet